Tag: Rapid Medical
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
Rapid Medical completes initial neurovascular cases in USA with Drivewire 24...
Rapid Medical has announced the first procedures in the USA with the breakthrough deflectable access platform Drivewire 24, doing so at the ongoing Society of...
Rapid Medical completes successful stroke procedures with “world’s first” robotic thrombectomy...
Rapid Medical has announced what it claims is the first successful robotic thrombectomy, in Medellín, Colombia. Two patients were treated with the robotic Tigertriever—an...
Rapid announces Japanese approval and exclusive partnership with Kaneka for Tigertriever
Rapid Medical has announced Japanese approval for its Tigertriever revascularisation device. With Pharmaceuticals and Medical Devices Agency (PMDA) approval, Tigertriever serves as “the first...
Tigertriever device produces high treatment-success rate in challenging ICAD stroke patients
Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD)....
Rapid Medical announces enrolment of final patient in post-market SUCCESS study
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the...
Rapid gains Chinese NMPA regulatory approval for Tigertriever thrombectomy device
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer...
Rapid Medical announces new data showing “significant advantages” of Comaneci for...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...
Rapid Medical gains US FDA clearance for “smallest and only” adjustable...
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...
Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke...
Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...
Rapid Medical announces Eitan Havis as international president
Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular...
Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment
Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
First US ischaemic stroke patients treated with Rapid Medical’s novel clot...
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...
Tigertriever receives FDA clearance following ISC presentation
Rapid Medical has announced the US Food and Drug Administration (FDA) clearance of its Tigertriever revascularisation device for use in the treatment of ischaemic stroke. According...
Rapid Medical receives FDA clearance for steerable neurovascular guidewire
Rapid Medical has announced its Drivewire novel guidewire with a steerable distal top, has received US Food and Drug Administration (FDA) clearance. According to...
Rapid Medical receives CE mark for remodelling mesh device
Rapid Medical has announced that its adjustable remodelling mesh device, called Comaneci, has received CE mark approval. Comaneci is intended to treat cerebral vasospasm...
Rapid Medical’s Tigertriever XL receives CE mark approval
Rapid Medical has announced CE mark approval for Tigertriever XL stentriever. The company noted that the first patients have been treated successfully with the...
Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device
Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
First patient enrolled in TIGER pivotal clinical study
The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...
First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry
The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...
Rapid Medical announces $9M in new funding
Rapid Medical has completed a Series B financing of $9M to advance the commercialisation of the company’s minimally invasive stroke treatment and prevention products, the Tigertriever...
Rapid Medical reaches 500 successful aneurysm treatments with Comaneci
Rapid Medical has announced that its Comaneci adjustable remodelling mesh has exceeded 500 successfully treated aneurysms worldwide. This milestone comes two years after the...
First stroke patient treated with Rapid Medical’s Tigertriever
Rapid Medical’s Tigertriever has been used to treat its first patient. Using Rapid Medical’s proprietary technology, this stent retriever is designed to be fully...
First stroke patient treated with Rapid Medical’s Tigertriever
Using Rapid Medical's proprietary technology, this stent retriever is designed to be fully visible and controllable. The device can be adjusted by physicians to fit the dimensions of blood vessels causing acute ischaemic stroke, and is the first of its kind, according to the company.
First clinical report on Comaneci device shows good aneurysm occlusion
In the Journal of NeuroInterventional Surgery (JNIS), Tufail Patankar (Department of Neuroradiology, Leeds Teaching Hospital, Leeds, UK) and colleagues present the first clinical report...
